TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34414491

Group type: EXPERIMENTAL
Intervention: Locking plate fixation with elimination of irreducible intercalary fragments (Group 1)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Locking plate fixation for noncomminuted fractures (Group 2)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Locking plate fixation (Group 1)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Locking plate fixation (Group 2)
Number of subjects: 65
Study: 34801802

Group type: EXPERIMENTAL
Intervention: Proficiency-based training
Number of subjects: 9

Group type: COMPARATOR
Intervention: Standard training
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Both training groups
Number of subjects: 9
Study: 35028171

Group type: EXPERIMENTAL
Intervention: Comfrey ointment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 36036296

Group type: EXPERIMENTAL
Intervention: External attentional focus instructions
Number of subjects: 40

Group type: COMPARATOR
Intervention: Internal attentional focus instructions
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Supra-postural tasks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Postural tasks
Number of subjects: 40
Study: 33022105

Group type: EXPERIMENTAL
Intervention: K-well-nourished E. urophylla × camaldulensis clone under severe water deficit
Number of subjects: 2

Group type: COMPARATOR
Intervention: E. urophylla with severe water deficit
Number of subjects: 2
Study: 32915777

Group type: EXPERIMENTAL
Intervention: Genetically determined increase in HDL levels
Number of subjects: 215551

Group type: EXPERIMENTAL
Intervention: Multivariable MR analysis adjusting for LDL, TGs, BMI, and age at menarche
Number of subjects: 215551

Group type: EXPERIMENTAL
Intervention: Genetic variants independent of leading association at core HDL pathway genes
Number of subjects: 215551
Study: 35180097

Group type: EXPERIMENTAL
Intervention: Low-frequency pulsed electromagnetic fields and TCM kneading manipulation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Oral Aceclofenac sustained-release tablets, calcium carbonate and vitamin D3 tablets
Number of subjects: 80
Study: 32800469

Group type: EXPERIMENTAL
Intervention: Double balloon catheter
Number of subjects: 21

Group type: COMPARATOR
Intervention: Prostaglandin pessary
Number of subjects: 21
Study: 34391293

Group type: EXPERIMENTAL
Intervention: Dry needling
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Between group comparison
Number of subjects: 40
Study: 32040183

Group type: EXPERIMENTAL
Intervention: List experiment method (treatment group)
Number of subjects: 786

Group type: COMPARATOR
Intervention: Control group (non-sensitive items)
Number of subjects: 786

Group type: EXPERIMENTAL
Intervention: Registered FSWs
Number of subjects: 786

Group type: EXPERIMENTAL
Intervention: PrEP demonstration project enrollment
Number of subjects: 786
Study: 35422869

Group type: EXPERIMENTAL
Intervention: Acupuncture with standard antiemetics (Arm A)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard antiemetics only (Arm C)
Number of subjects: 42
Study: 32479591

Group type: EXPERIMENTAL
Intervention: Integrated intervention (in-depth assessment, personalised care plans, and coordinated care)
Number of subjects: 453

Group type: COMPARATOR
Intervention: Control group (group education session on frailty prevention)
Number of subjects: 453
Study: 35139572

Group type: EXPERIMENTAL
Intervention: Carbohydrate Counting Method (CCM)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Traditional Method (TM)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: CCM
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Both methods (CCM and TM)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Cesarean delivery
Number of subjects: 89
Study: 35612399

Group type: EXPERIMENTAL
Intervention: Resistance Exercise (RE)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 30
Study: 34625598

Group type: EXPERIMENTAL
Intervention: Exenatide (EXE)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Insulin glargine (GLAR)
Number of subjects: 159
Study: 32295524

Group type: EXPERIMENTAL
Intervention: Health TAPESTRY intervention
Number of subjects: 84
Study: 35272982

Group type: EXPERIMENTAL
Intervention: Baduanjin qigong intervention
Number of subjects: 28

Group type: COMPARATOR
Intervention: Active control condition (light flexibility exercise)
Number of subjects: 28
Study: 32682507

Group type: EXPERIMENTAL
Intervention: Heated fennel therapy
Number of subjects: 381
Study: 36397122

Group type: EXPERIMENTAL
Intervention: 12 sessions of posterior cingulate cortex (PCC) ISF‐NFB up‐training (n=15)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 12 sessions of concurrent PCC ISF up‐training and dorsal anterior cingulate cortex (dACC) ISF‐NFB down‐training (n=15)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 6 sessions of yoked‐sham training followed by 6 sessions genuine ISF‐NFB (n=30)
Number of subjects: 60
Study: 33498640

Group type: EXPERIMENTAL
Intervention: Low sodium meal plan (0.9 mg/kcal)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Typical sodium meal plan (2 mg/kcal)
Number of subjects: 20
Study: 32285223

Group type: EXPERIMENTAL
Intervention: AT13148 treatment in BT474 and PC3 cells
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AT13148 treatment in non-tumor bearing mice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AT13148 treatment in patients at doses of 160-300 mg
Number of subjects: 0
Study: 34453027

Group type: EXPERIMENTAL
Intervention: Single-task balance training
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Dual-task balance training
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 69
Study: 33775927

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) targeting the bilateral dorsolateral prefrontal cortex
Number of subjects: 781

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 781

Group type: EXPERIMENTAL
Intervention: High- and low-frequency rTMS
Number of subjects: 781

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 781
Study: 32001397

Group type: EXPERIMENTAL
Intervention: Early intensive rehabilitation management (from 7 days after injury, 7 d/wk, 4 times/d, 1 h/session) for 4 weeks
Number of subjects: 87

Group type: COMPARATOR
Intervention: Ordinary rehabilitation (from 14 days after injury, 5 d/wk, 2 times/d, 1 h/session) for 4 weeks
Number of subjects: 87
Study: 34665023

Group type: EXPERIMENTAL
Intervention: Intravitreal dexamethasone with silicone tamponade (Group-1)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Silicone tamponade only (Group-2)
Number of subjects: 43
Study: 33221117

Group type: EXPERIMENTAL
Intervention: Peer-led intervention (6-week, six 90-minute group-based training sessions)
Number of subjects: 359

Group type: EXPERIMENTAL
Intervention: Peer-led intervention
Number of subjects: 359

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 359
Study: 36929955

Group type: EXPERIMENTAL
Intervention: Change4Life Food Scanner app (version 1.6) for 3 months
Number of subjects: 126

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Change4Life Food Scanner app
Number of subjects: 126
Study: 32375348

Group type: EXPERIMENTAL
Intervention: 6000 IU/d cholecalciferol (vitamin D)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Natural sun exposure (WSE)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Natural sun exposure (SSE)
Number of subjects: 28
Study: 34444656

Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg/kg of body mass)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 32047952

Group type: EXPERIMENTAL
Intervention: Favorite music (Group M)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Standard care (Group C)
Number of subjects: 117
Study: 36246968

Group type: EXPERIMENTAL
Intervention: Neural mobilization combined with cervical isometric exercises
Number of subjects: 88

Group type: COMPARATOR
Intervention: Cervical isometric exercises alone
Number of subjects: 88
Study: 33906239

Group type: EXPERIMENTAL
Intervention: Active break intervention (N=47)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Postural shift intervention (N=46)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Control group (N=100)
Number of subjects: 193
Study: 32475989

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg ketamine infusion
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 30
Study: 36201455

Group type: EXPERIMENTAL
Intervention: 100 g/day of fermented vegetables (group A)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 100 g/day pickled vegetables (group B)
Number of subjects: 31

Group type: COMPARATOR
Intervention: No vegetables (group C)
Number of subjects: 31
Study: 34377210

Group type: EXPERIMENTAL
Intervention: Health Schools educational programs
Number of subjects: 590
Study: 33208512

Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate (DMPA-IM)
Number of subjects: 7829

Group type: COMPARATOR
Intervention: Copper intrauterine device (IUD)
Number of subjects: 7829

Group type: EXPERIMENTAL
Intervention: Levonorgestrel (LNG) implant
Number of subjects: 7829
Study: 33342434

Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 35924603

Group type: EXPERIMENTAL
Intervention: Flapless technique
Number of subjects: 24

Group type: COMPARATOR
Intervention: Flap technique
Number of subjects: 24
Study: 34189135

Group type: EXPERIMENTAL
Intervention: Norepinephrine infusion during general anesthesia
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group (no norepinephrine)
Number of subjects: 129
Study: 32958495

Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 3100

Group type: EXPERIMENTAL
Intervention: Remdesivir + SoC
Number of subjects: 3100

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir + SoC
Number of subjects: 3100

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir associated with interferon (IFN)‐β‐1a + SoC
Number of subjects: 3100

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine + SoC
Number of subjects: 3100
Study: 35363301

Group type: EXPERIMENTAL
Intervention: Samotolisib (LY3023414) 200 mg twice daily plus enzalutamide 160 mg daily
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo plus enzalutamide 160 mg daily
Number of subjects: 142
Study: 36273481

Group type: EXPERIMENTAL
Intervention: Monofilament suture
Number of subjects: 2049

Group type: COMPARATOR
Intervention: Braided suture
Number of subjects: 2049
Study: 32502164

Group type: EXPERIMENTAL
Intervention: Exergames during three 40-minute classes
Number of subjects: 140

Group type: COMPARATOR
Intervention: Traditional PE classes (three routine curricular classes)
Number of subjects: 140
Study: 35025817

Group type: EXPERIMENTAL
Intervention: Evolocumab 420 mg monthly subcutaneous injection
Number of subjects: 467

Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 467
Study: 34391876

Group type: EXPERIMENTAL
Intervention: Multimodal nonopioid analgesic protocol
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard opioid regimen
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 48
Study: 32622171

Group type: EXPERIMENTAL
Intervention: Active tDCS at 2 mA for 15 sessions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 0
Study: 35256899

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilator‐assisted ventilation nursing combined with mechanical vibration
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional nursing intervention
Number of subjects: 120
Study: 33094652

Group type: EXPERIMENTAL
Intervention: Mindful breathing
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Body scan
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Observing-thoughts meditation
Number of subjects: 75

Group type: COMPARATOR
Intervention: Active control (reading and discussing a book about mindfulness)
Number of subjects: 75
Study: 32756643

Group type: EXPERIMENTAL
Intervention: Probiotic therapy (Lactobacillus para casei LPC‐37, Lactobacillus rhamnosus HN001, Lactobacillus acidophilus NCFM, Bifidobacterium lactis HN019, 109 CFU of each strain) for 8 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Probiotic therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (polydextrose 1 g day‐1 for 8 weeks)
Number of subjects: 40
Study: 36001989

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg BID with aspirin 100 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin 100 mg daily alone
Number of subjects: 0
Study: 34319665

Group type: EXPERIMENTAL
Intervention: Digital diagnostic waxing (DW)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional diagnostic waxing (DW)
Number of subjects: 20
Study: 34235978

Group type: EXPERIMENTAL
Intervention: Circulating biomarkers (6 selected: glial cell‐derived neurotrophic factor, glial fibrillary acidic protein, S100 calcium‐binding protein B, stem cell factor, fibroblast growth factor [FGF] 23, FGF19)
Number of subjects: 80
Study: 36187334

Group type: EXPERIMENTAL
Intervention: RP jelly drink
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo jelly drink
Number of subjects: 43
Study: 33742324

Group type: EXPERIMENTAL
Intervention: Immediate intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 40
Study: 32051025

Group type: EXPERIMENTAL
Intervention: Intervention focused on reducing sedentary time through individually tailored, progressive goals to replace sedentary time with standing and light-intensity activities.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified in the abstract.
Number of subjects: 0
Study: 35830143

Group type: EXPERIMENTAL
Intervention: Neutral fluoride gel (NFG)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Fluoride varnish (FV)
Number of subjects: 240
Study: 33050974

Group type: EXPERIMENTAL
Intervention: Messages focusing on 'benefits' of packing healthy lunchboxes
Number of subjects: 511

Group type: EXPERIMENTAL
Intervention: Messages focusing on 'barriers' of packing healthy lunchboxes
Number of subjects: 511

Group type: COMPARATOR
Intervention: Messages from different sources (dietitian, university, health promotion team, school)
Number of subjects: 511

Group type: COMPARATOR
Intervention: Personalised messages based on child's name or grade level
Number of subjects: 511
Study: 36075594

Group type: EXPERIMENTAL
Intervention: Scraping needling technique combined with western medication
Number of subjects: 68

Group type: COMPARATOR
Intervention: Simple western medication (control group)
Number of subjects: 68
Study: 34914281

Group type: EXPERIMENTAL
Intervention: CS+JJP
Number of subjects: 90

Group type: COMPARATOR
Intervention: CS
Number of subjects: 90

Group type: COMPARATOR
Intervention: JJP
Number of subjects: 90
Study: 36041176

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet made entirely from organic foods
Number of subjects: 27

Group type: COMPARATOR
Intervention: Mediterranean Diet made from conventional foods
Number of subjects: 27
Study: 32020130

Group type: EXPERIMENTAL
Intervention: L-PRF application after surgical removal of impacted third molar
Number of subjects: 18

Group type: COMPARATOR
Intervention: No graft inserted after extraction (Control)
Number of subjects: 18
Study: 32844679

Group type: EXPERIMENTAL
Intervention: HBT+ACT
Number of subjects: 102

Group type: COMPARATOR
Intervention: HBT
Number of subjects: 102
Study: 33027708

Group type: EXPERIMENTAL
Intervention: 60 min of skin‐to‐skin contact
Number of subjects: 88

Group type: COMPARATOR
Intervention: 5 min of visual contact with their mother
Number of subjects: 88
Study: 35018760

Group type: EXPERIMENTAL
Intervention: Thiamazole treatment for 5-8 months
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Thiamazole treatment for 9-12 months
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Thiamazole treatment for more than 12 months
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 135
Study: 36314172

Group type: EXPERIMENTAL
Intervention: Tegoprazan 25 mg
Number of subjects: 351

Group type: COMPARATOR
Intervention: Lansoprazole 15 mg
Number of subjects: 351
Study: 34233975

Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 2200

Group type: COMPARATOR
Intervention: Multivitamin
Number of subjects: 2200
Study: 33123304

Group type: EXPERIMENTAL
Intervention: Brief acceptance and commitment therapy (individual condition)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Brief acceptance and commitment therapy (group condition)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 7
Study: 35100768

Group type: EXPERIMENTAL
Intervention: Adolescents
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Parents
Number of subjects: 300

Group type: COMPARATOR
Intervention: Other topics
Number of subjects: 300
Study: 34620199

Group type: EXPERIMENTAL
Intervention: Time-restricted feeding (10-h restricted feeding treatment program; ad libitum feeding from 8:00 to 18:00 h; fasting between 18:00 and 8:00 h) for 12 weeks
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Time-restricted feeding
Number of subjects: 120
Study: 35078268

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA (OBTX‐A) injection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sacral neuromodulation (SNM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Human expert predictions
Number of subjects: 0
Study: 33651384

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation exercises performed twice a day for 5 days
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 67
Study: 35388776

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (ICBT) for 5 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group-based face-to-face cognitive-behavioral therapy (CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list (WL)
Number of subjects: 0
Study: 34498941

Group type: EXPERIMENTAL
Intervention: Peer instruction (n = 93)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Conventional group work (n = 93)
Number of subjects: 186
Study: 33212796

Group type: EXPERIMENTAL
Intervention: Caregivers with 3 months of ≥25% decrease in cotinine levels
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Low caregiver cotinine levels
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Caregiver anxiety and depression outcomes (measured by PHQ-4 scores)
Number of subjects: 90
Study: 36418137

Group type: EXPERIMENTAL
Intervention: Continuous suture with additional interrupted retention sutures (MonoMax 1 and Vicryl 2)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Standard continuous suture (MonoMax 1)
Number of subjects: 222
Study: 33143906

Group type: EXPERIMENTAL
Intervention: Educational peer group intervention (two interactive group sessions)
Number of subjects: 319
Study: 32710787

Group type: EXPERIMENTAL
Intervention: 15N-labeled milk protein concentrate (25 g - low protein)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 15N-labeled milk protein concentrate (50 g - high protein)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 15N-labeled milk protein (high protein)
Number of subjects: 10
Study: 33719775

Group type: EXPERIMENTAL
Intervention: TOWER intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 34491113

Group type: EXPERIMENTAL
Intervention: Exergame-based dual-task training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Home-based multicomponent exercise training
Number of subjects: 20
Study: 34254976

Group type: EXPERIMENTAL
Intervention: Higher abdominal fat deposition
Number of subjects: 755

Group type: EXPERIMENTAL
Intervention: Higher waist circumference (WC)
Number of subjects: 755

Group type: EXPERIMENTAL
Intervention: Higher hip circumference (HC)
Number of subjects: 755

Group type: EXPERIMENTAL
Intervention: Waist-hip ratio (WHR)
Number of subjects: 755
Study: 32072742

Group type: EXPERIMENTAL
Intervention: iGlarLixi (n = 255)
Number of subjects: 512

Group type: COMPARATOR
Intervention: iGlar (n = 257)
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 512

Group type: COMPARATOR
Intervention: iGlar
Number of subjects: 512
Study: 33066723

Group type: EXPERIMENTAL
Intervention: Ecopipam (25–100 mg/day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 33867497

Group type: EXPERIMENTAL
Intervention: Resistance Exercise Training (RET)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Endurance Exercise Training (ENT)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Detraining after RET and HIIT
Number of subjects: 35
Study: 35172928

Group type: EXPERIMENTAL
Intervention: Personal amplifier
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Hearing screening
Number of subjects: 11
Study: 34836058

Group type: EXPERIMENTAL
Intervention: High dose of CMR (3% - 750 mg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Moderate dose of CMR (2% - 500 mg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Low dose of CMR (1% - 250 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sweetened water (placebo)
Number of subjects: 14
Study: 35704122

Group type: EXPERIMENTAL
Intervention: Foam Rolling (FR)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Foam Rolling with Vibration (VFR)
Number of subjects: 30
Study: 32297719

Group type: EXPERIMENTAL
Intervention: Guanfacine extended-release (GXR)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study: 37714408

Group type: EXPERIMENTAL
Intervention: Beam F3 targeting (n=58)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 5.5 cm targeting (n=47)
Number of subjects: 105
Study: 35409532

Group type: EXPERIMENTAL
Intervention: Coaching group (n = 26) participated in a 7-day guided hiking program with three personal coaching sessions
Number of subjects: 58

Group type: COMPARATOR
Intervention: Hiking group (n = 32) received no coaching
Number of subjects: 58
Study: 32139384

Group type: EXPERIMENTAL
Intervention: Metformin increased by ≥1,000 mg/day
Number of subjects: 6823

Group type: EXPERIMENTAL
Intervention: Metformin unchanged
Number of subjects: 6823

Group type: EXPERIMENTAL
Intervention: Metformin decreased
Number of subjects: 6823
Study: 36461899

Group type: EXPERIMENTAL
Intervention: STN-DBS
Number of subjects: 201

Group type: COMPARATOR
Intervention: BMT
Number of subjects: 201